MAP Pharmaceuticals Inc. (NASDAQ:MAPP) Investor Alert: Lawsuit to Halt Takeover by Allergan, Inc
An investor in shares of MAP Pharmaceuticals Inc. (NASDAQ:MAPP) filed a lawsuit in effort to stop the proposed takeover of MAP Pharmaceuticals Inc by Allergan, Inc for $25.00 per NASDAQ:MAPP share.
View full press release